Cellectricon AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cellectricon AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3387
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cellectricon AB (Cellectricon) is an advanced cell-based discovery service provider. The company offers automated cell-based screening technologies for drug discovery and basic research. It provides Cellaxess, a platform that allows the researchers to address critical bottlenecks in the drug discovery process. Cellectricon’s therapeutic areas include Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, schizophrenia and chronic pain. The company’s services help researchers to identify phenotypic effects in relevant biological models early enough in a project’s lifecycle. The company also provides scientific support services. It serves biotech, pharma and academic organizations. Cellectricon is headquartered in Gothenburg, Sweden.

Cellectricon AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cellectricon AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cellectricon AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cellectricon AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cellectricon AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cellectricon AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cellectricon AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cellectricon Enters into Agreement with Censo Biotech 10
Cellectricon Enters into Agreement with Neurexpert 11
Cellectricon Enters Into Distribution Agreement With Novel Science 12
Cellectricon Enters Into Distribution Agreement With Nepa Gene 13
Licensing Agreements 14
Fluicell Enters into Licensing Agreement with Cellectricon 14
Cellectricon AB – Key Competitors 15
Cellectricon AB – Key Employees 16
Cellectricon AB – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Jul 13, 2018: Cellectricon strengthens its expertise in neurodegenerative diseases by the appointment of new Scientific Advisory Board member Professor Henrik Zetterberg 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Cellectricon AB, Pharmaceuticals & Healthcare, Key Facts 2
Cellectricon AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cellectricon AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cellectricon AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cellectricon AB, Deals By Therapy Area, 2012 to YTD 2018 8
Cellectricon AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cellectricon Enters into Agreement with Censo Biotech 10
Cellectricon Enters into Agreement with Neurexpert 11
Cellectricon Enters Into Distribution Agreement With Novel Science 12
Cellectricon Enters Into Distribution Agreement With Nepa Gene 13
Fluicell Enters into Licensing Agreement with Cellectricon 14
Cellectricon AB, Key Competitors 15
Cellectricon AB, Key Employees 16

List of Figures
Cellectricon AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cellectricon AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cellectricon AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cellectricon AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cellectricon AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cellectricon AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cellectricon AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cellectricon AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Cellectricon AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shoaibi Group:石油・ガス:M&Aディール及び事業提携情報
    Summary Shoaibi Group (Shoaibi) is a provider of manufacturing, services, product distribution and investment programs. The company provides active venture capital and private equity investments. It offers services such as marketing and technical services, finance and taxation, public relations, adm …
  • Nanosonics Ltd (NAN):製薬・医療:M&Aディール及び事業提携情報
    Summary Nanosonics Ltd (Nanosonics) is a medical technology company, which focuses on the development of technologies for infection control. Its product portfolio includes decontamination products and accessories for the prevention of hospital acquired infections (HAI). The company’s trophon EPR is …
  • Hooker Furniture Corporation (HOFT):企業の財務・戦略的SWOT分析
    Hooker Furniture Corporation (HOFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Rubius Therapeutics Inc (RUBY):製薬・医療:M&Aディール及び事業提携情報
    Summary Rubius Therapeutics Inc (Rubius Therapeutics) is a biotechnology company that focuses on the development of medicines for the treatment of rare diseases, cancer and autoimmune diseases. The company through its rubius erythrocyte design (RED) platform engineer and culture Red Cell Therapeutic …
  • University of Chicago-製薬・医療分野:企業M&A・提携分析
    Summary University of Chicago (UOC) is an academic and research university that offers education and research in various disciplines. The university offers undergraduate, master’s and PhD programs in the areas of anthropology, art history, astronomy and astrophysics, biochemistry and molecular biolo …
  • Response Biomedical Corp:企業の戦略的SWOT分析
    Response Biomedical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Novaliq GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops novel ophthalmic and dermatological products, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears, a pres …
  • Ithaca Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Ithaca Energy Inc. (Ithaca), a subsidiary of Delek Group Ltd., is an oil and gas company, which explores for, develops, and produces oil and gas in the North Sea. It focuses on the appraisal and development of undeveloped discoveries and the exploitation of its existing UK producing asset po …
  • Arete Industries Inc (ARET):企業の財務・戦略的SWOT分析
    Summary Arete Industries Inc (Arete Industries) is an oil and gas company that operates pipeline stations. The company operates a natural gas gathering system located in Campbell County, Wyoming. Arete Industries gas gathering systems comprise coated steel pipeline transporting coal bed methane. The …
  • STRATEC Biomedical AG (SBS):企業の財務・戦略的SWOT分析
    Summary STRATEC Biomedical AG (STRATEC), formerly Stratec Biomedical Systems AG is a medical equipment provider that develops and manufactures automated systems for clinical diagnostics. The company provides instrumentation, data management, molecular solutions, and others. It offers data management …
  • Bellicum Pharmaceuticals Inc (BLCM):企業の財務・戦略的SWOT分析
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …
  • Taiwan Semiconductor Manufacturing Company Limited
    Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report Summary Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Taylor Wimpey Plc:戦略・SWOT・企業財務分析
    Taylor Wimpey Plc - Strategy, SWOT and Corporate Finance Report Summary Taylor Wimpey Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Zoll Medical Corporation-医療機器分野:企業M&A・提携分析
    Summary ZOLL Medical Corporation (Zoll), a subsidiary of Asahi Kasei Corporation, is a provider of medical devices and software solutions for advance emergency care. The company designs, manufactures and markets resuscitation devices and systems used for resuscitation and acute critical care victims …
  • Advanced Biological Laboratories SA-医療機器分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • Veracyte Inc (VCYT):企業の財務・戦略的SWOT分析
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also …
  • The Straits Trading Co Ltd:企業の戦略・SWOT・財務情報
    The Straits Trading Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Straits Trading Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Futuren (FTRN):電力:M&Aディール及び事業提携情報
    Summary Futuren, previously Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The com …
  • National Institute on Drug Abuse-製薬・医療分野:企業M&A・提携分析
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …
  • Post Holdings, Inc.:戦略・SWOT・企業財務分析
    Post Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Post Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆